Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
Philips’ Duo Venous Stent System receives FDA approval and completes first implant
chronic venous insufficiency, Duo Venous Stent System, Philips, stent, VIVID study, /in Cardiology, Product News /by panglobalRoyal Philips has announced the successful first implantation of its Duo Venous Stent System following premarket approval from the U.S. Food and Drug Administration. The device is indicated for treating symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI).
Philips unveils innovative Cardiac Workstation to expedite diagnostic cardiology
Cardiac Workstation, clinical decision support, interoperability, Philips, workflow, /in Cardiology, Product News /by panglobalRoyal Philips, a leader in health technology, has launched a new cardiac care platform aimed at transforming diagnostic cardiology in Europe, the Middle East, and Africa. The Philips Cardiac Workstation utilises sophisticated algorithms to expedite the collection and processing of electrocardiograph (ECG) data, potentially streamlining care and helping to prioritise high-risk patients.
WHO Europe report exposes industry tactics fuelling NCD epidemic
alcohol, corporates, NCDs, tobacco, ultra-processed foods, WHO, /in Editors' Picks, Featured Articles, Non Communicable Diseases /by panglobalA groundbreaking report from the WHO Regional Office for Europe reveals how powerful industries are driving the non-communicable disease crisis across Europe and central Asia. The report calls for urgent action to protect public health policies from corporate interference.
GE HealthCare unveils groundbreaking head-only MRI scanner
GE Healthcare, MRI, neuroimaging, SIGNA MAGNUS, /in Imaging, Product News /by panglobalGE HealthCare has introduced SIGNA MAGNUS, a novel head-only magnetic resonance imaging (MRI) scanner designed to advance neuroscience research. The device, which is currently pending FDA 510(k) clearance (it is not yet CE marked), aims to overcome the performance limitations of conventional whole-body MR systems that have historically constrained neurological and psychiatric research.
Large study shows pulsed field ablation technique safe and effective for atrial fibrillation treatment
atrial fibrillation, MANIFEST-17K, pentaspline, pulsed field ablation, /in Cardiology, E-News /by panglobalA groundbreaking study involving over 17,000 patients has demonstrated the safety of pulsed field ablation (PFA) for treating atrial fibrillation. The MANIFEST-17K trial, led by researchers from the Icahn School of Medicine at Mount Sinai, provides compelling evidence that this novel technique avoids many of the complications associated with traditional thermal ablation methods.
Delaying diabetes onset by four years significantly reduces mortality and complication risks
lifestyle intervention, mortality risk, PLOS Medicine, prediabetes, type 2 diabetes, /in E-News, Lifestyle Diseases /by panglobalNew research demonstrates that individuals with prediabetes can substantially improve their long-term health outcomes by postponing the onset of type 2 diabetes for just four years through lifestyle modifications.
Twice-yearly injection of Gilead’s lenacapavir achieves 100% protection in landmark HIV prevention trial
Gilead Sciences, HIV, lenacapavir, PrEP, PURPOSE 1 trial, /in Communicable Diseases, E-News /by panglobalGilead Sciences’ twice-yearly injectable lenacapavir demonstrated complete protection against HIV infection in a landmark Phase 3 trial, potentially revolutionising HIV prevention strategies for vulnerable populations.
Toxic metals detected in tampons: New study raises health concerns
Environment International, menstruation, Research, tampons, toxic metals, /in E-News, Women's Health /by panglobalA pioneering study from UC Berkeley has detected toxic metals, including arsenic and lead, in commercially available tampons. This unprecedented research raises urgent questions about potential health risks for millions of women who use these products and calls for increased scrutiny of feminine hygiene product safety.
Brain imaging and machine learning reveal six subtypes of depression
depression, functional MRI, Stanford Medicine, talk therapy, venlafaxine, /in E-News, Neurology /by panglobalA groundbreaking study led by Stanford Medicine researchers has unveiled six distinct biological subtypes of depression using brain imaging and machine learning techniques. This discovery could change the approach to diagnosing and treating depression, potentially leading to more effective, personalised interventions.
World first Bionic Liver-in-Cube wins gold medal at Geneva International Exhibition of Inventions
drug screening, HKUMed, invention, liver cancer, liver-in-cube, /in E-News, Oncology /by panglobalHKUMed team’s technology set to revolutionise liver cancer care A groundbreaking innovation in liver cancer treatment has earned international recognition for a team of researchers from the University of Hong Kong’s LKS Faculty of Medicine (HKUMed). Their ‘Bionic Liver-in-Cube: A Comprehensive Precise Theranostics for Liver Cancer and Diseases’ (‘Liver-in-Cube’) technology was awarded a Gold Medal […]